Business
BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2020
BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2020.
About this update from Bioqual, Inc.
[{"type":"text","content":"\nBIOQUAL, Inc. (OTC Pink: BIOQ) ( www.bioqual.com):\n\n\n\n\n \n\n\n \n\nSix Months Ended\nNovember 30,\n\n\n\n \n\n\n\nThree Months Ended\nNovember 30,\n\n\n\n\n\n \n\n\n \n\n2019\n\n\n\n \n\n\n\n2018\n\n\n\n \n\n\n\n2019\n\n\n\n \n\n\n\n2018\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\nRevenue \n\n\n \n\n$\n\n\n\n21,290,838\n\n\n \n\n$\n\n\n\n18,014,347\n\n\n \n\n$\n\n\n\n11,222,962\n\n\n \n\n$\n\n\n\n8,361,478\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\nIncome Before Income Tax \n\n\n \n\n$\n\n\n\n3,132,524\n\n\n \n\n$\n\n\n\n1,698,986\n\n\n \n\n$\n\n\n\n1,258,041\n\n\n \n\n$\n\n\n\n811,813\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\nNet Income \n\n\n \n\n$\n\n\n\n2,216,324\n\n\n \n\n$\n\n\n\n1,201,986\n\n\n \n\n$\n\n\n\n891,841\n\n\n \n\n$\n\n\n\n574,313\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\nBasic Earnings per Share of Common Stock \n\n\n \n\n$\n\n\n\n2.48\n\n\n \n\n$\n\n\n\n1.35\n\n\n \n\n$\n\n\n\n1.00\n\n\n \n\n$\n\n\n\n.64\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\nDiluted Earnings per Share of Common Stock \n\n\n \n\n$\n\n\n\n2.48\n\n\n \n\n$\n\n\n\n1.35\n\n\n \n\n$\n\n\n\n1.00\n\n\n \n\n$\n\n\n\n.64\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\nWeighted Average Number of Shares Outstanding For Basic Earnings Per Share\n\n\n\n\n \n\n\n\n 893,416\n\n\n \n\n \n\n\n\n 893,416\n\n\n \n\n \n\n\n\n893,416\n\n\n \n\n \n\n\n\n893,416\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\nWeighted Average Number of Shares Outstanding For Diluted Earnings Per Share\n\n\n \n\n \n\n\n\n893,838\n\n\n \n\n \n\n\n\n893,579\n\n\n \n\n \n\n\n\n893,838\n\n\n \n\n \n\n\n\n893,579\n\n\n\n\n\nFor more detail related to the fiscal year 2020 unaudited second quarter results, please visit our web site at www.bioqual.com.\n\n\nStatements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts; the Company’s ability to obtain new governme...